Banghulot, Raymie H.

HRN: 25-78-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/29/2024
08/30/2024
IVT
4g
Q6 X 24 Hours
S/P Pelvic Lap
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: